Xtant Medical Holdings (XTNT) Operating Expenses (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Operating Expenses data on file, last reported at $19.5 million in Q3 2025.

• On a quarterly basis, Operating Expenses fell 3.15% year-over-year to $19.5 million in Q3 2025; TTM through Dec 2025 was $58.3 million, a 27.4% decrease from a year earlier, with the FY2024 full-year figure at $80.3 million, up 22.35% from the prior year.
• Operating Expenses for Q3 2025 stood at $19.5 million, down from $19.7 million in the prior quarter.
• Over the last five years, Operating Expenses for XTNT reached as high as $21.5 million in Q2 2024 and fell as low as $8.1 million in Q1 2021.
• Historically, Operating Expenses has averaged $14.7 million across 5 years, with a median of $13.8 million in 2023.
• Across the five-year window, Operating Expenses decreased 26.24% in 2021 and jumped 108.8% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $9.6 million in 2021, then rose by 4.41% to $10.0 million in 2022, then surged by 108.8% to $20.9 million in 2023, then retreated by 14.5% to $17.9 million in 2024, then gained by 8.63% to $19.5 million in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were $19.5 million in Q3 2025, $19.7 million in Q2 2025, and $19.2 million in Q1 2025.